Expert Interviews
Dr. Karine Tawagi speaks with Dr. Adam Brufsky about notable data presented at SABCS 2024.
Dr. Adam Brufsky provides an overview on the best treatments in metastatic TNBC space, including Trodelvy.
Drs. Karine Tawagi and Adam Brufsky discuss the challenges of navigating treatment in patients with mTNBC.
Dr. Cytryn provides insights on the FDA approval of zolbetuximab and how it will impact clinical practice.
Len Usvyat spoke with Nephrology Times about the use of artificial intelligence in kidney care.
Dr. Anne Marie Morse talks about parasomnias, and how they affect quality of life in people who have them.
Deborah Brown shares key findings from the recently released seventh annual "State of Lung Cancer" report.
The campaign kicked off on November 1 to coincide with Lung Cancer Awareness Month.
Deborah Brown shares how the American Lung Association and its LUNG FORCE initiative are raising awareness this month.
Dr. MarkAlain Déry opines on micro and macro level systemic changes that are needed to improve health care amid hurricanes.
Hurricanes Helene and Milton had a deleterious impact on medical dispensing. Dr. Dery details the impact of these shortages.
Dr. Déry talks about how health disparities are amplified during hurricanes, and which communities are most impacted.
Dr. Déry details, with the use of specific examples, how hurricanes negatively impact the mental health of HCPs.
Dr. Déry provides a comprehensive overview of mass casualty protocols and how they are implemented during hurricanes.
Dr. MarkAlain Déry details the dangers associated with power failures at health care facilities, and how they are managed.
In the 20 years post-Hurricane Katrina, many natural disaster protocols have changed in an effort to improve preparedness.
There are a plethora of obstacles, especially regarding infrastructure, that health care facilities face during hurricanes.
Dr. Studts discusses why Lung Cancer Awareness Month is a critical time to inspire action, engagement, and hope.
Dr. John Fruehauf, Evolent, talks about a new standard of care in the treatment of stage III melanoma.
Researchers conducted an extensive analysis of PM2.5 exposure based on residential history, satellite data, and more.
Jonathan Barratt discussed his research on the anti-APRIL antibody sibeprenlimab in the treatment of IgA nephropathy.
Advertisement
Advertisement
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.